|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0800 THB | 0.00% |
|
0.00% | -52.94% |
| 07-20 | X Bioscience Reports Higher Impairment Charges in Q1 | MT |
| 07-16 | X Bioscience Public Company Limited Announces CEO Changes | CI |
| Market Cap | 972M 29.49M 25.51M 23.82M 21.85M 41.1M 2.81B 41.75M 279M 110M 1.41B 111M 108M 4.65B | P/E 2024 |
-2.62x | P/E 2025 | -0.15x |
|---|---|---|---|---|---|
| Enterprise Value | 1.21B 36.64M 31.69M 29.6M 27.15M 51.06M 3.49B 51.88M 347M 136M 1.75B 138M 135M 5.78B | EV / Sales 2024 |
4.31x | EV / Sales 2025 | 3.2x |
| Free-Float |
12.34% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 month | +33.33% | ||
| Current year | -52.94% |
| 1 week | 0.07 | 0.09 | |
| 1 month | 0.07 | 0.1 | |
| Current year | 0.04 | 0.18 | |
| 1 year | 0.04 | 2.87 | |
| 3 years | 0.04 | 6.79 | |
| 5 years | 0.04 | 35.35 | |
| 10 years | 0.04 | 147 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 54 | 01/08/2026 | |
| Director of Finance/CFO | - | 27/04/2026 | |
Anucha Ritpakdee
CTO | Chief Tech/Sci/R&D Officer | - | 01/05/2014 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 51 | 13/05/2022 | |
Phurit Wongkham
BRD | Director/Board Member | 40 | 25/02/2026 |
| Director/Board Member | 43 | 16/05/2025 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| 0.00% | 0.00% | -92.38% | -98.53% | 29.49M | ||
| +0.94% | -0.36% | -18.65% | +31.76% | 84.38B | ||
| +1.26% | +1.91% | -3.20% | +33.42% | 66.32B | ||
| -0.71% | +4.22% | -10.64% | +5.91% | 58.57B | ||
| +0.66% | +3.11% | +5.52% | +60.62% | 57.13B | ||
| +1.78% | +1.74% | -1.19% | +85.95% | 52.87B | ||
| +0.78% | +0.20% | +53.00% | +152.42% | 20.49B | ||
| +0.99% | +3.82% | +15.67% | +139.85% | 18.96B | ||
| +0.10% | -0.65% | -7.91% | +72.15% | 10.3B | ||
| +0.51% | +3.96% | -23.52% | +129.20% | 7.97B | ||
| Average | +0.60% | +1.70% | -8.33% | +61.27% | 37.7B | |
| Weighted average by Cap. | +0.77% | +1.73% | -2.77% | +55.16% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 319M 9.68M 8.38M 7.82M 7.18M 13.5M 922M 13.71M 91.78M 36.02M 462M 36.37M 35.57M 1.53B | 130M 3.93M 3.4M 3.18M 2.91M 5.48M 374M 5.57M 37.27M 14.63M 188M 14.77M 14.45M 620M |
| Net income | -260M -7.89M -6.83M -6.38M -5.85M -11M -751M -11.18M -74.81M -29.36M -377M -29.64M -28.99M -1.24B | -469M -14.22M -12.3M -11.49M -10.54M -19.82M -1.35B -20.14M -135M -52.91M -678M -53.41M -52.24M -2.24B |
| Net Debt | 345M 10.48M 9.06M 8.46M 7.76M 14.6M 997M 14.83M 99.29M 38.97M 500M 39.34M 38.48M 1.65B | 236M 7.15M 6.18M 5.78M 5.3M 9.97M 680M 10.12M 67.76M 26.6M 341M 26.85M 26.26M 1.13B |
Employees
399
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/08/26 | THB 0.0800 | 0.00% | 1,144,003 |
| 07/08/26 | THB 0.0800 | 0.00% | 657,300 |
| 06/08/26 | THB 0.0800 | 0.00% | 4,239,101 |
| 05/08/26 | THB 0.0800 | -11.11% | 384,673 |
| 04/08/26 | THB 0.0900 | +12.50% | 2,221,555 |
- Stock Market
- Stocks
- XBIO Stock
Select your edition
All financial news and data tailored to specific country editions
















